BioInvent International AB is a clinical-stage biopharmaceutical company based at Ideon Science Park in Lund. The company specializes in the discovery and development of first-in-class antibody-based cancer immunotherapies using its proprietary n-CoDeR and F.I.R.S.T technology platforms. Founded in 1997 and listed on Nasdaq Stockholm, BioInvent employs around 110-140 people and has multiple assets in clinical trials for hematological and solid tumors.
bioinvent.comPart of: Skåne Startup map